Navigation Links
China Yingxia International, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
Date:5/12/2008

s.

Safe Harbor Statement

The statements contained herein that are not historical facts are 'forward-looking statements' within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as 'believes,' 'expects,' 'may,' 'will,' 'should,' or 'anticipates,' 'expect' or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets or forecasting financial results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Company Contact:

Ms. Yingxia, Jiao

Chief Executive Officer

China Yingxia International, Inc

Tel: +86-451-8631-0948

Email: gy335577@163.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Elite Investor Relations

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Website: http://www.ccgelite.com


'/>"/>
SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
2. Secretary Leavitt Travels to the Peoples Republic of China to Check Up on Efforts to Improve Product Safety
3. China Medicine Announces Conference Call to Discuss First Quarter 2008 Results
4. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
5. The American Psychiatric Associations Awards for Young Scientists Encourage Research Expertise in China
6. Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks on a Regulatory Policy Speaking Tour in China in May
7. China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits
8. Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup
9. Increase in Travel to China Creating New Health and Security Risks
10. China-Biotics, Inc. Expands Retail Network to 60 Shining Retail Centers
11. China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...24 /PRNewswire/ -- MediVoice(R), LLC, the,world,s ...h and,e-Prescribing, has formed a strategic partne...teractive, web-based, patient-centered health reco...o integrate and market its,mobile voice-activation...OC) system., "MediVoice is pleased to develop a s...
(Date:7/23/2008)...wswire/ -- Philip J. Dwyer, president and CEO,of t...ny before the U.S.,Senate Health, Education, Labor... and Families today to call for increased funds fo...nted at YMCAs across the nation, that will,help re...e on behalf of the more than 2,600 YMCAs, that -- ...
(Date:7/23/2008)...migration and Naturalization ready at Passport ...uly 23 /PRNewswire/ -- New vaccine requirements wi...visa for entry into the U.S. and,anyone seeking ad...ants,must show proof of vaccinations against vacci.... Advisory Committee on Immunization Practices.,Pa...
(Date:7/23/2008)...008) Biodiversity has long been recognized by EPA ...rely on healthy ecosystems to provide food, clean ...he connection between disease and biodiversity (th...n a geographic region). Recent studies suggest th... diseases such as Lyme disease and West Nile encep...
Breaking Medicine News(10 mins):Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 2Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 3Health News:USCIS Tightens Vaccination Requirements 2Health News:Could preserving biodiversity reduce disease? 2
...od testing in children of Mt Isa today to determin...over emissions from Xstrata's two Mount Isa smelte...on Agency raised concerns about the need for healt... Blood sample will be collected from 400 children ...
... genes, REG1A and EXTL3 in the patients with color...ding to a new study from the Max Delbrueck Center ...ssion was also significantly higher in surgical bi...us colon polyps, or adenomas. "The findings sugg...
... output of nerve cells is the messenger of informa...ll unclear about how widely separated regions of t...r to assist a complex activity. A new study by neu...keley, and neurosurgeons and neurologists at UC Sa...
...nes is needed to make them more user-friendly and ...he latest edition of the Medical Journal of Austra... care has become a major feature of health care, y...recommendations are frequently not applied in prac...
Other Medicine News:Health News:REG1A and its receptor EXTL3 signal the recurrence of colorectal cancer 2Health News:Slow brain waves integral in coordination of complex activity 2Health News:Getting More Out of Guidelines 2
(Date:7/21/2008)...on use of Zevalin as consolidation therapy after ...ts with follicular ... -- Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTA:...led,a meeting with the U.S. Food and Drug Administ...ty of filing a supplemental Biologics License,Appl...
(Date:7/21/2008)...wire/ -- The SEAS (Simvastatin and Ezetimibe in,Ao...of intensive,cholesterol lowering with the combina...0 mg daily) in patients with aortic stenosis., Ao...the aortic valve in,the heart) is a relatively com...ons. Left untreated, it can progress to death from...
(Date:7/21/2008)...is a Must for Clinical Trials Management, WASHING...ation of,Academic Health Centers (AAHC) today laun...designed to assist academic health center leaders,...icers in establishing,strengthening, and improvin...ch enterprise, particularly to manage and support ...
(Date:7/21/2008)...ewswire/ -- Bioimpedance spectroscopy (BIS) is,mor...linical assessment of,lymphedema in breast cancer ...ly 20 issue of Journal of Clinical Oncology (2008;...ema After Breast Cancer: Incidence, Risk Factors, ...hored by Sandra Hayes, PhD.,and colleagues from Q...
Breaking Medicine Technology:CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4New AAHC Toolkit Available to Optimize Clinical Research Administration 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted 1168 1Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted 1168 2Thermo Fisher Scientific Acquires Leader in Micro Volume Spectrophotometers NanoDrop Technologies 1166 1Thermo Fisher Scientific Acquires Leader in Micro Volume Spectrophotometers NanoDrop Technologies 1166 2Thermo Fisher Scientific Acquires Leader in Micro Volume Spectrophotometers NanoDrop Technologies 1166 3SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT 40776 for the Treatment of Overactive Bladder 1164 1SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT 40776 for the Treatment of Overactive Bladder 1164 2Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 1Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 2Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 3Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 4Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 5
... 05, 2007 /PRNewswire-FirstCall/ --,Nuvelo, Inc. t...linical study of novel monoclonal antibodies again...trate that NTB-A is a,potential new target for imm...ia and lymphomas. The study, entitled "The lymphoi...antibody target for,leukemia and lymphoma therapeu...
...SS WIRE)--Jun 5, 2007 - NovaDel Pharma,Inc. (AMEX:...ng,oral spray formulations for a broad range of ma...inical studies comparing zolpidem,oral spray with ...netic (PK), pharmacodynamic (PD) and safety object...mbien(R), a leading,drug for the treatment of inso...
Other Medicine Technology:Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7
...nstruments are designed to provide distraction of ...ate preparation, and insertion of interbody grafts... Intradiscal Wedges, Spanners, Nerve Root Retracto...(Anterior Thoracic Interbody Fusions), TLIF, PLIF,...
...let Concentrate System is a point-of-care system d...entrate (also referred to as Platelet Rich Plasma ... sample of blood. The Symphony II PCS concentrates...d in the platelets. The platelet concentrate can b...
...et gel has an extensive base of experience and kno... concentrated autologous platelets are mixed with ...tional changes involved in coagulation take place....rs including serotonin, fibronectin, adenosine dip...
The Leica 2D video system offers you two smart solutions for microsurgical video imaging. The Leica 2D pick-up system, an integrated camera module to fit on all Leica M-series and the Leica 2D C-moun
Medicine Products: